ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GLPG Galapagos NV

29.36
0.27 (0.93%)
Last Updated: 05:07:57
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Galapagos NV GLPG NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.27 0.93% 29.36 05:07:57
Open Price Low Price High Price Close Price Previous Close
29.33 29.00 29.655 29.09
more quote information »

Recent News

Date Time Source Heading
03/5/202406:01GLOBEGalapagos reports first quarter 2024 financial results  
01/5/202406:01GLOBEGalapagos’ shareholders adopt all resolutions proposed by..
05/4/202407:01GLOBEGalapagos showcases innovative approach in hematological..
29/3/202407:01GLOBEGalapagos publishes 2023 annual report and announces Annual..
27/3/202407:01GLOBEGalapagos appoints Andrew Dickinson as Non-Executive..
23/2/202422:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/2/202408:01GLOBEGalapagos announces full year 2023 results and outlook for..
16/2/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/2/202408:01GLOBEGalapagos presents at EBMT-EHA annual meeting 2024
15/2/202409:41EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202408:01GLOBEGalapagos completes transaction to transfer Jyseleca®..
05/1/202408:44DJNGalapagos, Thermo Fisher to Collaborate on Expanding..
05/1/202408:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202408:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202408:01GLOBEGalapagos enters into strategic collaboration agreement with..
04/1/202408:01GLOBEGalapagos establishes strategic collaboration with BridGene..
02/1/202417:00GLOBEGalapagos signs agreement to transfer Jyseleca® business to..
22/12/202308:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202308:01GLOBEGalapagos announces start of PAPILIO-1 Phase 1/2 multiple..
10/12/202304:00GLOBEGalapagos presents new encouraging data at ASH 2023 from..
08/12/202308:01GLOBEGalapagos to Host KOL Event on December 10, 2023, at 11:00..
06/11/202323:45PRNUSLandmark Bio Signs Multi-Year Agreement to Manufacture..
03/11/202323:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202307:01GLOBEGalapagos reports third quarter 2023 results and releases..
02/11/202322:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202307:01GLOBEGalapagos concludes strategic evaluation and signs letter of..
20/9/202306:01GLOBEGalapagos appoints Simon Sturge to its Board of Directors
29/8/202306:01GLOBEGalapagos announces start of Phase 2 study with selective..
05/8/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/8/202306:01GLOBEGalapagos announces first half-year 2023 financial results
16/6/202306:01GLOBEGalapagos appoints Thad Huston as Chief Financial Officer..
13/6/202306:01GLOBEGalapagos appoints Dr. Susanne Schaffert as non-executive..
06/6/202306:01GLOBEGalapagos to showcase CAR-T point-of-care manufacturing and..
24/5/202306:01GLOBEGalapagos announces start of Phase 2 study with selective..
23/5/202306:01GLOBEGalapagos demonstrates commitment to immunology with new..

Your Recent History

Delayed Upgrade Clock